A carregar...
Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS
OBJECTIVE: To determine the safety of intrathecal autologous adipose-derived mesenchymal stromal cell treatment for amyotrophic lateral sclerosis (ALS). METHODS: Participants with ALS were enrolled and treated in this phase I dose-escalation safety trial, ranging from 1 × 10(7) (single dose) to 1 ×...
Na minha lista:
| Publicado no: | Neurology |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5123559/ https://ncbi.nlm.nih.gov/pubmed/27784774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003359 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|